
-
Finland open Women's Euro 2025 with win over Iceland
-
India captain Gill hits another hundred against England in 2nd Test
-
Hamas mulls truce proposals after Trump Gaza ceasefire push
-
Alcaraz ends Tarvet's Wimbledon adventure, Sabalenka advances
-
Tears, prayers, exultation: Diddy radiates relief after partial acquittal
-
Ruthless Alcaraz ends Tarvet's Wimbledon fairytale
-
Bangladesh collapse in ODI series opener to hand Sri Lanka big win
-
Trump says Vietnam to face 20% tariff under 'great' deal
-
US senator urges bribery probe over Trump-Paramount settlement
-
Nazi-sympathising singer's huge gig to paralyse Zagreb
-
Germany swelters as European heatwave moves eastwards
-
Sabalenka tells troubled Zverev to talk to family about mental health issues
-
Hong Kong govt proposes limited recognition of same-sex couples' rights
-
Wall Street shrugs off drop US private sector jobs
-
Spain star Bonmati recovering well from meningitis, says coach Tome
-
Pogacar must 'battle' for Tour de France title says director
-
Tesla reports lower car sales but figures better than feared
-
Alcaraz aims to avoid Wimbledon giant-killing after Sabalenka wins
-
England captain Stokes makes Jaiswal breakthrough in second Test
-
Sean 'Diddy' Combs acquitted of sex trafficking, convicted on lesser charge
-
Sabalenka praying for no more Wimbledon upsets after battling win
-
Hamas says discussing proposals after Trump Gaza ceasefire push
-
Teen plotting attacks on women charged in France's first 'incel' case
-
Sabalenka overcomes Bouzkova challenge to reach Wimbledon third round
-
Stocks stuck as US private sector jobs disappoint, UK's Reeves future uncertain
-
Asalanka ton leads Sri Lanka to 244 in first Bangladesh ODI
-
UK govt backs finance minister after tears in parliament
-
US private sector shed jobs for first time in recent years: ADP
-
Chelsea sign Brazil striker Joao Pedro from Brighton
-
Farrell says slow-starting Lions still have work to do
-
French court convicts ex-Ubisoft bosses for workplace harassment
-
Freeman at the double as slick Lions romp past Reds 52-12
-
India's Jaiswal on the attack against England in second Test
-
Liverpool defender Quansah signs for Bayer Leverkusen
-
Alcaraz aims to avoid giant-killing after Wimbledon seeds tumble
-
Freeman at the double as Lions sweep past Queensland Reds 52-12
-
Iran ends cooperation with UN nuclear watchdog after Israel, US strikes
-
Matildas' defender Carpenter leaves Lyon for Chelsea
-
Public or private? Funding debate splits reeling aid sector
-
Stocks diverge as tariffs deadline looms
-
EU unveils long-delayed 2040 climate target -- with wiggle room
-
Central Europe swelters as heatwave moves east
-
Hong Kong to regain IPO crown this year, say PwC and Deloitte
-
Iran suspends cooperation with UN nuclear watchdog
-
Israel's top diplomat urges seizing chance after Trump ceasefire push
-
Australia cancels Kanye West visa over 'Heil Hitler' song
-
Israel FM calls to seize opportunity as Trump pushes for Gaza ceasefire
-
Fire that closed Heathrow traced to unrepaired transformer
-
Gaza rescuers say Israeli strikes kill 14 as Trump teases ceasefire push
-
Asian markets mixed as trade deal cut-off looms

The suffering of those who cannot feel pain
Patrice Abela first knew something was wrong when his eldest daughter was learning to walk and her feet left trails of blood behind her, yet she showed no sign of distress.
She was soon diagnosed with congenital insensitivity to pain, an extremely rare and dangerous genetic disorder that dooms sufferers to a lifetime of hurting themselves in ways they cannot feel.
Abela, a 55-year-old software developer in the southern French city of Toulouse, then watched in horror as his youngest daughter was revealed to have the same condition.
Now aged 12 and 13, the two girls spend around three months of every year in hospital.
"When they take a shower, they perceive hot and cold, but if it burns they don't feel anything," the father of four told AFP.
"Due to repeated infections, my eldest daughter lost the first joint of each of her fingers. She also had to have a toe amputated."
Repeated knee injuries have left both girls only able to move around using crutches or a wheelchair.
Abela said they may not feel physical pain but lamented their intense "psychological pain".
Aiming to raise awareness about the disease and "challenge the scientific community", Abela plans to run the equivalent of 90 marathons in fewer than four months. He plans to start on April 12, following the route of this year's Tour de France from Copenhagen to Paris.
- Danger everywhere -
A life without pain might sound like a dream come true but the reality is more like a nightmare.
There are only a few thousand known cases of the condition worldwide. The low number is believed to be partly due to sufferers often not living into adulthood.
"Pain plays a major physiological role in protecting us from the dangers of our environment," said Didier Bouhassira, a doctor at the centre for pain evaluation and treatment at Ambroise-Pare hospital in Paris.
In the most extreme cases, babies will "mutilate their tongue or fingers while teething", he told AFP.
Then comes "a lot of accidents, burns, walking on fractured limbs which heal badly", he added.
"They have to be taught what is innate in others: to protect themselves."
But when there are no warning signs, danger lurks everywhere.
Appendicitis, which announces itself in others via symptoms like pain and fever, can fester into a devastating general infection of the abdomen.
"Blindness can also occur because the eye must always be kept moist and the nervous system controls these processes via the so-called blink reflex," said Ingo Kurth of Germany's Institute of Human Genetics.
- New painkiller hopes -
Congenital insensitivity to pain (CIP) was first recognised in the 1930s, and numerous studies have since identified a genetic mutation that blocks a person's ability feel pain.
"We have learned that there are now more than 20 genetic causes of congenital or progressive insensitivity to pain," Kurth told AFP.
There is no cure and "no real drug breakthroughs have been made so far", Kurth said.
"But our understanding of the molecular causes of CIP continues to reveal new targets, and based on this, hopefully new therapies will be developed in the coming years."
There are also hopes that studying how CIP works could lead to the development of a new kind of painkiller, prompting huge interest from pharmaceutical giants seeking a fresh product in the billion-dollar industry of pain relief.
In this way, the unlucky few with CIP could contribute to the creation of a treatment that would help everyone in the world -- except themselves.
P.Stevenson--AMWN